EMEA-000892-PIP01-10
Key facts
| Active substance |
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/160/2010
|
| PIP number |
EMEA-000892-PIP01-10
|
| Pharmaceutical form(s) |
Gel
|
| Condition(s) / indication(s) |
Treatment of acne vulgaris
|
| Route(s) of administration |
Cutaneous use
|
| Contact for public enquiries |
MEDA Pharma GmbH & Co. KG
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
| Compliance procedure number |
EMEA-C-000892-PIP01-10
|
| Compliance opinion date |
10/12/2010
|
| Compliance outcome |
positive
|